The molecular mechanism of ginsenoside Rh2 and its octyl ester derivative on anti-angiogenesis in cancer treatment: The battle between PI3K and ROS

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 921e0b991e87cff5-LAX IP: 101.37.83.79 UTC time: 2025-03-17T17:00:13+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4